POSTER SESSION IV
Tuesday, March 10, 2009   —  1:00 PM - 4:30 PM
Hynes CC Exhibit Hall C/D


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...




PATHOBIOLOGY



Poster#Title and AuthorsItinerary
Planner
196 Regulation of Rad18 Via the Ataxia Telangiectasia and Rad3 Related Kinase (1536)
AU Gurkar, C Vaziri - Boston University, Boston, MA
Add
197 c-Jun Amplification and Overexpression Are Oncogenic in Liposarcoma but Not Sufficient To Inhibit Adipocytic Differentiation (1553)
EL Snyder, DJ Sandstrom, K Law, E Sicinska, M Loda, SJ Rodig, P Dal Cin, CDM Fletcher - Brigham and Women's Hospital, Boston, MA; Dana Farber Cancer Institute, Boston, MA
Add
198 Reverse Phase Protein Lysate Array: Use in Identifying Function for Estrogen-Induced Gene 121 (1532)
L Deng, B Hennessy, R Broaddus - M.D. Anderson Cancer Center, Houston, TX
Add
199 Gossypol Suppresses In Vitro Head and Neck Squamous Cell Carcinoma Growth through Its Inhibition of DNA Methyltransferase 1 and Epigenetic Activation of Tumor Suppressor Genes (1534)
CY Fan, C Xie, H Zhang, YC Lin, JY Suen - University of Arkansas for Medical Sciences, Little Rock, AR; John L. McClellan Memorial Veterans Hospital, Little Rock, AR; The Ohio State University, Columbus, OH
Add
200 Topographic Relationship of High-Grade PIN with Atrophy and Adenocarcinoma (1539)
D Hull, MK Jarmulowicz, J Ma, J Qian, DG Bostwick - Bostwick Laboratories, Glen Allen, VA
Add
201 Pulmonary Endotoxin Tolerance Protects Against Lung Injury While Maintaining Capacity To Clear Bacterial Pathogens (1546)
S Natarajan, J Kim, DG Remick - Boston University School of Medicine, Boston, MA
Add
202 Immunohistochemical Study of Hace1 in Wilms' Tumor and Breast Cancer Suggests a Pro-Tumorigenic Role for Its Nuclear Isoform (1547)
T Ng, F Zhang, J Mathers, B Rotblat, D Fink, V Friedrich, A Li, H Joensuu, P Sorensen - BC Cancer Research Centre, Vancouver, BC, Canada; University of British Columbia, Vancouver, BC, Canada; Helsinki University Central Hospital, Helsinki, Finland
Add
203 Adenosine but Not Diazoxide or Ischemic Preconditioning Significantly Rescues Myocardial Injury in HIF-1alpha Deficient Heart (1560)
H Zhong, K Fox-Talbot, D Zagzag, G Semenza - New York University School of Medicine, New York, NY; Johns Hopkins University School of Medicine, Baltimore, MD
Add
204 Regulation of VEGF-Induced Vascular Permeability and VEGFR2 Signaling by Thrombospondin-1 (1559)
X Zhang, S Parangi, J Lawler - University of Chicago Medical Center, Chicago; Massachusetts General Hospital, Boston; Beth Israel Deaconess Medical Center, Boston, MD
Add
205 Does Epithelial-Mesenchymal Transition Underlie Breast Cancer Metastases? (1545)
H Nassar, J Hicks, A DeMarzo, M Halushka, S Sukumar, P Argani - Johns Hopkins Medical Institute, Baltimore, MD
Add
206 Holoclone and Non-Holoclone Derived Cell Lineage miRNA Analysis in Prostate Cancer (1549)
YM Salley, P Smyth, CM Martin, O Sheils, JJ O'Leary - Trinity College, Dublin 2, Ireland; Coombe Women and Infants University Hospital, Dublin 8, Ireland
Add
207 Expression of IMP3, an Oncofetal Protein, in Various Malignant Primary and Metastatic Neoplasms, a Study of 1099 Cases (1542)
D Lu, Y Zhou, M Kamionek, M Lyle, BA Woda, SY Hao, KL Rock, Z Jiang - UMass Memorial Healthcare, Worcester, MA
Add
208 Correlated Alterations in Prostate Basal Cell Layer and Basement Membrane (1541)
AJ Liu, YG Man, WA Gardner - Beijing 301 Hospital, Beijing, China; Armed Forces Institute of Pathology and American Registry of Pathology, Washington, DC
Add
209 Stem Cell Protein Piwil2 Variant PL2V60 Regulates Precancerous Stem Cell Proliferation (1551)
R Shen, Y Yin, D-T Yin, Q-T Yan, L Chen, G He, SH Barsky, J-X Gao - Ohio State University, Columbus, OH; The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Add
210 Detection of Chromosomal Anomalies in Chromophone Renal Cell Carcinoma Using Fluorescence In Situ Hybridization (1548)
J Qian, D Weber, D Hossain, L Liu, DG Bostwick - Bostwick Laboratories, Glen Allen, VA
Add
211 Expression of Abelson-Interactor Protein 1 in Breast Cancer and Its Association with Phospho-Akt (1556)
D Tran-Thanh, C Wang, T Cawthorn, D Wang, DR McCready, SJ Done - Ontario Cancer Institute, Toronto, ON, Canada; Princess Margaret Hospital, Toronto, ON, Canada; Toronto General Hospital, Toronto, ON, Canada
Add
212 The ALT Phenotype in Breast Carcinoma Is Associated with HER-2 Overexpression (1554)
AP Subhawong, P Argani, N Kouprina, H Nassar, R Vang, AK Meeker - The Johns Hopkins Hospital, Baltimore, MD
Add
213 Elucidating Signaling Networks in Clinical Tissues with Multispectral Imaging (1538)
T Hope, J Ruan, D Wang, R Levenson, H Gardner, C Hoyt - CRi, Inc., Woburn, MA; Novartis TBG, Cambridge, MA
Add
214 Comparison of Different Methods for Detecting K-ras Mutations in Colorectal Carcinomas (1550)
M Samara, K Kapatou, A Athanassiadis, GK Koukoulis - Medical School, University of Thessaly, Larissa, Greece; General Hospital, Larissa, Greece
Add
215 A New Phosphatase Involved in Human Carcinomas: Laforin Is Downregulated in a Large Set of Tumors, Supporting Its Role as Tumor Suppressor (1557)
MA Vazquez, C Parada, J Hernandez, S Landolfi, V Peg, R Somoza, S Rodriguez de Cordoba, S Ramon y Cajal - HU Vall Hebron, Barcelona, Spain; CSIC, Madrid, Spain
Add
216 Loss of Heterozygosities in Barrett Esophagus, Dysplasia and Adenocarcinoma (1561)
B Zhu, SD Finkelstein, BJ Ujevich, JF Silverman, X Lin - Northwestern University, Chicago, IL; RedPath Integrated Pathology, Inc, Pittsburgh, PA; Allegheny General Hospital, Pittsburgh, PA
Add
217 The Angiogenesis Regulator & Notch Pathway Activator Delta like Ligand 4 Is Widely Expressed by Vascular & Neoplastic Cells in Human Cancer and Relocates to the Nucleus. An Immunohistochemical and In-Situ Hybridization Study (1544)
JC Martinez, H Turley, G Steers, F Pezzella, KC Gatter - Hospital Universitario Ramon y Cajal, Madrid, Spain; John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom
Add
218 Altered Expression Pattern of Myocyte Enhancer Factor in Benign and Malignant Cartilaginous Tumors (1558)
GS Yu, L Balos, M de Peralta-Venturina, TJ Kuntzman, RK Malhotra, EG Bernacki, M Amin - William Beaumont Hospital, Royal Oak, MI; University at Buffalo, Buffalo, MI
Add
219 Lewis B Antigen Expression Is Lower in Breast Carcinoma and Is Associated with Hormone Receptor Status and Histological Type (1552)
K Simoes, IC Soares, A Wakamatsu, OK Okamoto, AA Jungbluth, VAF Alves, LJ Old - University of Sao Paulo School of Medicine, Sao Paulo, Brazil; Hospital de Clinical Luzia de Pinho Melo, UNIFESP, Sao Paulo, Brazil; Sao Paulo Federal University, Sao Paulo, Brazil; Ludwig Institute for Cancer Research, New York, NY
Add
220 The Adenosinergic A2A Receptor Prevents Exacerbation of Systemic Inflammation and Lung Inflammation Secondary to Polymicrobial Sepsis (1530)
BG Belikoff, S Hatfield, F Cracium, JA Buras, M Sitkovsky, DG Remick - Boston University School of Medicine, Boston, MA; Northeastern University, Boston, MA
Add